NVCR Stock Analysis: Buy, Sell, or Hold?
NVCR - NovoCure Limited Ordinary Shares
$18.05
-0.05 (-0.28%)
▼
5d:
+7.25%
30d:
+48.32%
90d:
+44.05%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Apr 30, 2026
0d
Smart Money Accumulation
NVCR is down 8.4% this week, but smart money is accumulating calls. Top strike: $15 2026-06-18 with 666 OI. Call ratio: 92% View Scanner →
Strength: 8.4/10
Get Alerted When NVCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: NVCR is 8.9% above its trading range ($16.57). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: NVCR is 8.9% above its trading range ($16.57). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: NVCR is currently trading at $18.05, which is considered extended relative to its 30-day fair value range of $11.08 to $16.57.
Technical Outlook: Technically, NVCR is in a strong downtrend. Immediate support is located at $15.35, while resistance sits at $18.92.
Market Sentiment: NVCR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.29 (+45.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NVCR is in a strong downtrend. Immediate support is located at $15.35, while resistance sits at $18.92.
Market Sentiment: NVCR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.29 (+45.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.08 -
$16.57
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
NVCR is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+8.9% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.6% below Wall St target ($26.29)
Trading Range Analysis
30-Day Trading Range
$11.08 -
$16.57
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$15.35
Resistance Level
$18.92
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.41
Wall Street Target
$26.29
(+45.6%)
Revenue Growth (YoY)
12.3%
Earnings Growth (YoY)
-6.0%
Profit Margin
-25.7%
Share & Embed Analysis
Last updated: May 15, 2026 4:35 AM ET
Data refreshes hourly during market hours. Next update: 5:35 AM
Data refreshes hourly during market hours. Next update: 5:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Mukund Paravasthu
SELL
43246 shares
2026-03-05
Christoph Brackmann
SELL
6412 shares
2026-03-04
Frank X Leonard
SELL
5607 shares
2026-03-04
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 58 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 52 HOLD |
Advanced NVCR Option Strategies
Professional options setups generated by AI based on today's NVCR price and gamma walls.
